| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-147 |
Sentence |
denotes |
Possible activation of an intramyocardial inflammatory process ( Staphylococcus aureus)after treatment with infliximab in a boy with Crohn disease. |
| T2 |
148-159 |
Sentence |
denotes |
UNLABELLED: |
| T3 |
160-335 |
Sentence |
denotes |
In an 11-year old boy with Crohn disease, long-term therapy with prednisolone was decided to be augmented by infliximab, a monoclonal antibody to tumour necrosis factor alpha. |
| T4 |
336-552 |
Sentence |
denotes |
The patient, who was in a stable clinical condition with low signs of inflammation at that time, deteriorated 3 days after the first dose of 200 mg infliximab with fever, nausea, myalgia and signs of cardiac failure. |
| T5 |
553-646 |
Sentence |
denotes |
Echocardiography demonstrated destruction of the aortic valve with third grade insufficiency. |
| T6 |
647-728 |
Sentence |
denotes |
In the blood culture, a susceptible strain of Staphylococcus aureus was isolated. |
| T7 |
729-863 |
Sentence |
denotes |
Antibiotic therapy resulted in rapid improvement, but the aortic valve had to be replaced by a homograft due to massive insufficiency. |
| T8 |
864-1113 |
Sentence |
denotes |
At surgery, there were no signs of endocarditic vegetations, the aortic ring and the right coronary aortic cusp had been destroyed by a massive intramyocardial abscess, leading from close beneath the aortic ring in the direction of the right atrium. |
| T9 |
1114-1201 |
Sentence |
denotes |
The size of the process suggested chronic infection or reinfection after several weeks. |
| T10 |
1202-1429 |
Sentence |
denotes |
As clinical and laboratory signs as well as echocardiographic changes pointed to a dramatic flare-up shortly after the administration of infliximab, we suggest that this chronic inflammatory process was activated by infliximab. |
| T11 |
1430-1585 |
Sentence |
denotes |
CONCLUSION: when using infliximab, special awareness of potential risks is necessary in patients with chronic infections or in a state of immunodeficiency. |
| T1 |
0-147 |
Sentence |
denotes |
Possible activation of an intramyocardial inflammatory process ( Staphylococcus aureus)after treatment with infliximab in a boy with Crohn disease. |
| T2 |
148-159 |
Sentence |
denotes |
UNLABELLED: |
| T3 |
160-335 |
Sentence |
denotes |
In an 11-year old boy with Crohn disease, long-term therapy with prednisolone was decided to be augmented by infliximab, a monoclonal antibody to tumour necrosis factor alpha. |
| T4 |
336-552 |
Sentence |
denotes |
The patient, who was in a stable clinical condition with low signs of inflammation at that time, deteriorated 3 days after the first dose of 200 mg infliximab with fever, nausea, myalgia and signs of cardiac failure. |
| T5 |
553-646 |
Sentence |
denotes |
Echocardiography demonstrated destruction of the aortic valve with third grade insufficiency. |
| T6 |
647-728 |
Sentence |
denotes |
In the blood culture, a susceptible strain of Staphylococcus aureus was isolated. |
| T7 |
729-863 |
Sentence |
denotes |
Antibiotic therapy resulted in rapid improvement, but the aortic valve had to be replaced by a homograft due to massive insufficiency. |
| T8 |
864-1113 |
Sentence |
denotes |
At surgery, there were no signs of endocarditic vegetations, the aortic ring and the right coronary aortic cusp had been destroyed by a massive intramyocardial abscess, leading from close beneath the aortic ring in the direction of the right atrium. |
| T9 |
1114-1201 |
Sentence |
denotes |
The size of the process suggested chronic infection or reinfection after several weeks. |
| T10 |
1202-1429 |
Sentence |
denotes |
As clinical and laboratory signs as well as echocardiographic changes pointed to a dramatic flare-up shortly after the administration of infliximab, we suggest that this chronic inflammatory process was activated by infliximab. |
| T11 |
1430-1585 |
Sentence |
denotes |
CONCLUSION: when using infliximab, special awareness of potential risks is necessary in patients with chronic infections or in a state of immunodeficiency. |